UCB SA (UCBJF)
250.59
-1.50
(-0.60%)
USD |
OTCM |
Sep 15, 16:00
UCB Market Cap : 47.78B for Sept. 15, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 15, 2026 | 47.78B |
| September 14, 2026 | 48.06B |
| September 11, 2026 | 46.93B |
| September 10, 2026 | 44.19B |
| September 09, 2026 | 46.99B |
| September 08, 2026 | 47.92B |
| September 04, 2026 | 48.68B |
| September 03, 2026 | 47.40B |
| September 02, 2026 | 50.35B |
| September 01, 2026 | 48.08B |
| August 31, 2026 | 47.83B |
| August 28, 2026 | 47.83B |
| August 27, 2026 | 51.02B |
| August 26, 2026 | 50.83B |
| August 25, 2026 | 50.97B |
| August 24, 2026 | 50.97B |
| August 21, 2026 | 50.16B |
| August 20, 2026 | 49.40B |
| August 19, 2026 | 49.83B |
| August 18, 2026 | 48.54B |
| August 17, 2026 | 48.54B |
| August 14, 2026 | 48.54B |
| August 13, 2026 | 50.16B |
| August 12, 2026 | 49.83B |
| August 11, 2026 | 50.41B |
| Date | Value |
|---|---|
| August 10, 2026 | 50.73B |
| August 07, 2026 | 51.35B |
| August 06, 2026 | 51.45B |
| August 05, 2026 | 51.45B |
| August 04, 2026 | 49.28B |
| August 03, 2026 | 50.30B |
| July 31, 2026 | 51.41B |
| July 30, 2026 | 49.49B |
| July 29, 2026 | 56.36B |
| July 28, 2026 | 53.48B |
| July 27, 2026 | 54.88B |
| July 24, 2026 | 55.32B |
| July 23, 2026 | 52.81B |
| July 22, 2026 | 52.81B |
| July 21, 2026 | 52.81B |
| July 20, 2026 | 54.07B |
| July 17, 2026 | 52.02B |
| July 16, 2026 | 53.22B |
| July 15, 2026 | 52.41B |
| July 14, 2026 | 51.72B |
| July 13, 2026 | 53.18B |
| July 10, 2026 | 53.86B |
| July 09, 2026 | 56.51B |
| July 08, 2026 | 56.32B |
| July 07, 2026 | 56.50B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Johnson & Johnson | 643.91B |
| Eli Lilly & Co. | 1.072T |
| Novo Nordisk A/S | 139.52B |
| Pfizer Inc. | 156.61B |
| Teva Pharmaceutical Industries Ltd. | 44.89B |
Market Cap Related Metrics
| PE Ratio | 19.00 |
| PS Ratio | 4.891 |
| PEG Ratio | 0.0212 |
| Price to Free Cash Flow | 34.55 |
| Price | 250.59 |
| Earnings Yield | 5.26% |
| PEGY Ratio | 0.0212 |
| Operating PE Ratio | 15.37 |
| Normalized PE Ratio | 18.84 |